Quantitative Market Risk Exposure Assessment: CARMAX INC
This report synthesizes an analysis of CARMAX INC's market risk disclosures from its SEC filing, focusing on exposure magnitude, mitigation strategies, and quantitative impacts across key financial risks.
Interest Rate Sensitivity
CARMAX faces interest rate risk through multiple funding sources, requiring distinct management approaches for each segment.
Non-Recourse Notes Payable (Primary Funding)
- Magnitude of Exposure: Total non-recourse notes payable were $17,119.8 million in 2025, with a variable-rate component totaling $6,186.7 million. This represents a substantial exposure to floating rate changes.
- Mitigation Strategies (Strength): The company actively mitigates this risk by entering into derivative instruments designed to manage differences between expected cash receipts and payments related to auto loan funding. Furthermore, the majority of the primary financing is structured through fixed-rate asset-backed term funding transactions ($10,933.1 million).
- Vulnerability (Weakness): Despite hedging efforts, a 100-basis point increase in market interest rates associated with these non-recourse vehicles would decrease fiscal 2025 net earnings per share by approximately $0.18, indicating significant sensitivity to rate hikes.
Other Debt and Pension Obligations
- Magnitude of Exposure: Substantially all borrowings under the revolving credit facility and term loan are variable-rate debt based on SOFR. The pension plan's Projected Benefit Obligation (PBO) is also sensitive to discount rates.
- Mitigation Strategies: Derivative instruments mitigate a portion of the variable-rate risk in other debt.
- Impact/Sensitivity: A 100-basis point increase in market interest rates related to other debt would decrease net earnings per share by approximately $0.01, which is significantly less impactful than the non-recourse notes exposure. For the pension plan, a 100-basis point change in the discount rate has an approximate 14% effect on the PBO balance.
Equity Price Risk
CARMAX's primary disclosed equity risk relates to compensation expense rather than direct investment portfolio mark-to-market losses.
- Magnitude of Exposure: The company utilizes cash-settled restricted stock units as liability awards, making related compensation expense sensitive to fluctuations in the company’s stock price.
- Quantitative Impact (Sensitivity): A 10% increase in the company's stock price would affect fiscal 2025 net earnings per share by approximately $0.03.
- Assessment: This exposure is managed through accounting mechanisms related to compensation, but it introduces a direct link between market valuation and reported earnings.
Foreign Currency Exposure
- Exposure Assessment: No foreign currency exposures or associated risks (translation or transaction risk) are disclosed in the provided filing excerpt.
Commodity Price Risk
- Exposure Assessment: No exposure to commodity price risk is disclosed in the provided filing excerpt.
Quantitative Measures and Stress Testing
While specific quantitative measures such as Value-at-Risk (VaR) are not disclosed, the company provides detailed sensitivity analysis that serves a similar function for key risks.
Sensitivity Analysis Disclosed
- Interest Rate Risk: The most significant quantified risk is tied to non-recourse notes payable, where a 100-basis point rate increase results in an estimated $0.18 decrease in EPS. This provides a clear measure of the downside impact under stress conditions.
- Equity Price Risk: A sensitivity table shows that a 10% stock price rise impacts net earnings by approximately $0.03 per share.
Assessment (Strength/Weakness)
- Strength: The disclosure of specific EPS impacts for interest rate and equity changes provides stakeholders with actionable, quantitative data regarding the financial consequences of market movements.
- Weakness: The absence of standard metrics like Value-at-Risk (VaR) or comprehensive stress test results limits the depth of the risk assessment available to external parties.